WA
BSX icon

Waddell & Associates’s Boston Scientific BSX Stock Holding History

Waddell & Associates’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$559K Buy
13,104
+1,888
+17% +$103K 0.03% 249
2026
Q1 		$704K Buy
+11,216
New +$897K 0.04% 156

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return

Waddell & Associates's BSX Position: Q2 2026 in Review

Waddell & Associates increased its Boston Scientific (BSX) stake by 17% in Q2 2026, buying an estimated $103K and bringing the position to 13,104 shares worth $559K. The position accounts for 0.03% of the portfolio, ranked #249.

Waddell & Associates first reported a position in BSX in Q1 2026 and has held it in 2 quarters since. The position peaked at $704K in Q1 2026. 420 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Waddell & Associates held 13,104 shares of Boston Scientific worth $559K as of Q2 2026.
  • Waddell & Associates bought 1,888 Boston Scientific shares in Q2 2026, an estimated $103K.
  • Boston Scientific made up 0.03% of Waddell & Associates's portfolio in Q2 2026, its #249 holding.
  • Waddell & Associates first reported a position in Boston Scientific in Q1 2026 and has held it in 2 quarters since.
  • Waddell & Associates's Boston Scientific position peaked at $704K in Q1 2026.
  • 420 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Waddell & Associates's 13F filing for Q2 2026, filed 15 Jul 2026.